Clinical Trial

Dexmedetomidine and Nalbuphine as Analgesic Adjuvants to Bupivacaine in Superficial Cervical Block.

Unknown Phase 4
View on ClinicalTrials.gov →
Record status
This record was last updated July 8, 2024 (before its estimated October 2024 completion). Its status may not reflect the trial's current state.
Summary
Anterior cervical discectomy and fusion (ACDF) nowadays is considered a common procedure.postoperative pain can hinder recovery and prolong hospital stay. The superficial cervical plexus block (SCPB) is a safe and simple technique that had been found to allow good pain relief in neck surgeries. The main drawback of SCPB was short duration, so adjuvants as dexmedetomidine and opioids has been used to increase analgesic duration and decrease the use of opioids. The current study will compare the efficacy of dexmedetomidine and nalbuphine as adjuvants to bupivacaine in SCPB in anterior cervical fusion surgeries.
Protocol Amendment History 1 change
critical Trial status changed: Not Yet Recruiting → Unknown 2026-08-02
Trial Details
NCT Number NCT06490614
Lead Sponsor Kasr El Aini Hospital
Conditions Anterior Cervical Discectomy and Fusion (ACDF)
Enrollment 30 participants
Start Date 2024-07
Primary Completion 2024-10 (estimated)
Study Completion 2024-11 (estimated)
Updated on ClinicalTrials.gov 2024-07-08